Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 217,035 shares at $116.03 ($25.1M) on 2023-05-01, disclosed to the SEC on 2023-05-02.
Open-market sale of $25.1M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.00 | 66,163 | $7.6M | 30.3% |
| 2 | $116.03 | 75,436 | $8.8M | 34.9% |
| 3 | $116.03 | 75,436 | $8.8M | 34.9% |
| Total | $115.72 avg | 217,035 | $25.1M | 100% |
| Filing → |
| MRK | SELL | 2026-02-06 | $4.6M | — | Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2022-11-01 | $33.0M | — | Filing → |